Page last updated: 2024-11-03

pyrimethamine and Leishmaniasis, Visceral

pyrimethamine has been researched along with Leishmaniasis, Visceral in 2 studies

Maloprim: contains above 2 cpds

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parra, LLL1
Bertonha, AF1
Severo, IRM1
Aguiar, ACC1
de Souza, GE1
Oliva, G1
Guido, RVC1
Grazzia, N1
Costa, TR1
Miguel, DC1
Gadelha, FR1
Ferreira, AG1
Hajdu, E1
Romo, D1
Berlinck, RGS1
Woodruff, AW1

Reviews

1 review available for pyrimethamine and Leishmaniasis, Visceral

ArticleYear
Recent work concerning anemia in the tropics.
    Seminars in hematology, 1982, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Anemia; Anemia, Hypochromic; Anemia, Megaloblastic; Animals; Child; Child, Presch

1982

Other Studies

1 other study available for pyrimethamine and Leishmaniasis, Visceral

ArticleYear
Isolation, Derivative Synthesis, and Structure-Activity Relationships of Antiparasitic Bromopyrrole Alkaloids from the Marine Sponge Tedania brasiliensis.
    Journal of natural products, 2018, 01-26, Volume: 81, Issue:1

    Topics: Alkaloids; Animals; Antimalarials; Antiparasitic Agents; Antiprotozoal Agents; Chagas Disease; Leish

2018